Eva McLellan is a purpose-driven transformational leader with nearly 20 years of global business leadership and management experience in biotechnology. Recognized as a forward-thinking strategist, she has dedicated her career to driving positive change in healthcare systems and improving patient outcomes. Having held senior global strategy and country leadership roles in Canada, Switzerland and BeLux, McLellan has also led significant strategic projects in emerging markets. Throughout her career, she has demonstrated a proven ability to build and lead teams that foster innovation, reshaping access to and the delivery of care in diverse areas such as early pipeline, infectious disease, oncology, haematology, rare diseases and digital health. As General Manager of Roche Pharma, McLellan’s external focus is on forging strong partnerships and scaling innovative approaches to shape health systems, enhance care and ensure equitable, sustainable access to innovation. In addition to her executive role, she actively contributes to the strategic direction of the industry, serving on the boards of the Bled Institute for Leadership in Digital Transformation and Artificial Intelligence (as Co-Chair), and the American Chamber of Commerce (as a member). Her commitment to advancing women in healthcare is evident from her past role as a regional council board member of the Healthcare Business Women's Association (HBA) in Europe in 2019. In 2021, McLellan co-founded Unlocking Eve, a global foundation in collaboration with Kaye Vitug. The foundation's mission is to unlock 100 million integrated leaders and foster a community of action (thinker-doers) to drive meaningful progress on Sustainable Development Goals #3 and #5. This initiative also involves pioneering research on new leadership models essential for achieving these goals. She holds an Honours Bachelor of Science and Masters of Biotechnology from the University of Toronto and is a graduate of INSEAD Business School’s Executive Management Program.